This page includes the latest FDA filings for Optinose Us Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
OptiNose US, Inc. | Prescription Medication | 2024-11-03 |
OptiNose US, Inc. | Prescription Medication | 2024-07-18 |
OptiNose US, Inc. | Prescription Medication | 2024-03-21 |
OptiNose US, Inc. | Prescription Medication | 2023-11-04 |
OptiNose US, Inc. | Prescription Medication | 2023-10-18 |
OptiNose US, Inc. | Prescription Medication | 2023-02-03 |
OptiNose US, Inc. | Prescription Medication | 2022-11-22 |
OptiNose US, Inc. | Prescription Medication | 2022-09-02 |
OptiNose US, Inc. | Prescription Medication | 2021-05-14 |
OptiNose US, Inc. | Prescription Medication | 2021-03-03 |
OptiNose US, Inc. | Prescription Medication | 2020-11-26 |
OptiNose US, Inc. | Prescription Medication | 2019-10-12 |
OptiNose US, Inc. | Prescription Medication | 2019-07-30 |
OptiNose US, Inc. | XHANCE | 2017-10-03 |
OPTINOSE US INC | 0000-00-00 00:00:00 |
NCAGE Code | 82S44 | OPTINOSE US, INC. |
CAGE Code | 82S44 | OPTINOSE US, INC. |
S.A.M. Registration | 82S44 [963350926] | OPTINOSE US, INC. |